Pneumonitis Induced By Anti-TB Medications: A Case Report

unilateral or bilateral focal infiltration of the upper lobe or the lower lobe(s), cavitation may be present, and inflammation with tissue destruction may result in fibrosis, traction and/or enlargement of hilar and mediastinal lymph nodes [7].Chest computed tomography (CT) is Abstract Pulmonary Tuberculosis (PTB), caused by Mycobacterium tuberculosis, is a potentially serious infectious disease that mainly affects the lungs, and it is a leading cause of infectious disease morbidity and mortality worldwide and resistance to commonly used anti tuberculous drugs is increasing [1].PTB may also disseminate (miliary TB) or affect almost any other organ (extra pulmonary TB): pleural cavity, pericardium, lymph nodes, gastrointestinal tract and peritoneum, genitourinary tract, skin, bones and central nervous system [2].Most commonly, PTB is transmitted via aerosol droplets from infectious patient.The global incidence of TB peaked around 2003 and appears to be declining slowly [1].However, PTB disease cases have been climbed since 2020 and increased 5% in 2022 but did not return to pre- pandemic levels [3].According to the World Health Organization (WHO), in 2021, 10.6 million individuals became ill with PTB and 1.6 million died, and globally in 2022, more than 410,000 people developed rifampin-resistant or multidrug-resistant (MDR) PTB [4].